Top 20 Clinical Trial & Research Laboratories 2025

This report forms part of the Ranking News Healthcare Ranking series, which evaluates hospitals, medical institutions, pharmaceutical organizations, medical technology companies, diagnostics providers, laboratories, precision medicine platforms, and healthcare systems across global healthcare markets.

Clinical trial and research laboratories occupy a critical position within the life sciences ecosystem by supporting pharmaceutical, biotechnology, medical device, academic, and contract research organizations throughout the drug development process. These laboratories provide the analytical, biological, biomarker, pathology, genomic, immunology, safety, and sample-management infrastructure required to evaluate investigational therapies from early discovery through late-stage clinical trials.

Unlike routine clinical laboratories serving everyday patient diagnostics, clinical trial and research laboratories are designed around regulated research workflows. Their services may include central laboratory testing, bioanalytical assays, pharmacokinetics, pharmacodynamics, biomarker testing, immunogenicity testing, genomics, flow cytometry, histopathology, companion diagnostics support, sample logistics, biorepository services, and laboratory data integration.

The sector has become more important as drug development becomes more biologically complex. Modern clinical trials increasingly involve targeted therapies, biologics, cell and gene therapies, immuno-oncology, rare disease programs, complex biomarkers, decentralized trial models, adaptive protocols, and global patient recruitment. These trends require laboratories capable of producing reliable, comparable, and regulatory-grade data across multiple countries and study sites.

This ranking identifies clinical trial and research laboratory providers whose platforms demonstrate sustained relevance across global central laboratory services, specialty testing, bioanalysis, biomarker science, preclinical research, clinical trial logistics, regulatory compliance, and life sciences partnerships. Rather than focusing only on revenue or facility count, the objective is to recognize organizations whose laboratory platforms play a meaningful role in the global research and drug development ecosystem.

Market Overview

The clinical trial and research laboratory sector sits at the intersection of diagnostics, contract research, biopharmaceutical development, and regulatory science. Its role is to generate reliable laboratory data that sponsors, investigators, regulators, and clinicians can use to assess drug safety, biological activity, patient eligibility, treatment response, and trial endpoints.

The market includes several provider types. Large global central laboratory platforms such as Labcorp Central Labs, IQVIA Laboratories, ICON Central Laboratories, Medpace Central Laboratories, and Thermo Fisher Scientific’s PPD laboratory services support multinational clinical trials with specimen collection, kit logistics, laboratory testing, data management, and regulatory-grade reporting. Labcorp states that its central laboratory services support clinical trial testing, bioanalytical testing, advanced diagnostics, precision medicine, and global data integration.

A second segment consists of specialty bioanalytical and biomarker laboratories. These providers support pharmacokinetic assays, pharmacodynamic markers, immunogenicity testing, ligand-binding assays, mass spectrometry, flow cytometry, cell-based assays, and translational biomarker development. Their relevance has increased as biologics, immunotherapies, antibody-drug conjugates, RNA medicines, and cell therapies require more complex analytical methods.

A third segment includes preclinical and translational research laboratories. Providers such as Charles River Laboratories and Eurofins BioPharma Product Testing support drug discovery, safety assessment, biologics testing, toxicology, analytical chemistry, and product characterization. Eurofins describes its biopharma product testing network as a large independent harmonized network of GMP laboratories serving pharmaceutical, biopharmaceutical, and medical device clients.

A fourth segment includes academic, reference, and hospital-linked research laboratories. These laboratories contribute specialty testing, rare disease assays, genomic interpretation, pathology expertise, and investigator-driven research support. They are especially important in oncology, immunology, infectious disease, neurology, pediatrics, and rare disease clinical trials.

The sector remains structurally attractive because clinical development continues to require high-quality outsourced laboratory infrastructure. Market research estimates placed the central lab services / clinical trial lab services market at approximately USD 5.97 billion in 2025, with projected growth toward USD 8.18 billion by 2030.

Industry Trend — 2025

The clinical trial and research laboratory industry in 2025 is shaped by five major trends: biomarker complexity, global trial execution, data integration, specialty medicine, and sponsor demand for scalable outsourcing partners.

First, biomarker complexity continues to increase. Modern trials often require genomic profiling, immune monitoring, cytokine panels, minimal residual disease testing, digital pathology, circulating tumor DNA, pharmacogenomics, and exploratory translational assays. Laboratories with strong scientific consultation and assay-development capability are increasingly valuable.

Second, global trial execution remains essential. Large studies require consistent sample handling, harmonized testing, regional laboratories, courier networks, investigator-site support, and data comparability across geographies. ICON states that its global central laboratory services are designed to deliver harmonized data for assessing drug efficacy and safety, supported by clinical informatics, scientific experience, technologies, and global reach.

Third, laboratory data integration is becoming a differentiator. Sponsors increasingly need real-time data flow, electronic requisitions, sample tracking, protocol-specific dashboards, investigator portals, and integration with electronic data capture systems. Labcorp’s Global Trial Connect initiative was launched to streamline investigator site workflows and support clinical trial efficiency through central laboratory solutions.

Fourth, specialty medicine is changing laboratory demand. Oncology, immunology, rare disease, metabolic disease, neurology, infectious disease, and cell and gene therapy trials frequently require highly specialized assays that cannot be handled by routine laboratories. Providers with validated specialty platforms and regulatory-grade assay documentation are well positioned.

Fifth, biopharmaceutical sponsors increasingly prefer integrated partners. Rather than managing many small laboratories across a trial, sponsors often seek central labs that can combine testing, logistics, biorepository services, project management, data handling, and specialty biomarker capability. IQVIA describes its laboratories as offering central laboratory and specialty biomarker services with a global footprint for drug discovery and development.

Methodology — Core Eligibility Criteria

To ensure structural consistency within the category, organizations considered for this ranking were evaluated based on the following eligibility conditions:

• Operates primarily as a clinical trial laboratory, central laboratory, bioanalytical laboratory, research laboratory, preclinical testing provider, biomarker laboratory, or life sciences laboratory services platform
• Provides services such as central lab testing, clinical trial specimen management, bioanalysis, pharmacokinetics, biomarker testing, immunogenicity testing, pathology, genomics, toxicology, biorepository services, or GMP / GLP analytical testing
• Maintains meaningful institutional scale through global laboratory networks, sponsor relationships, CRO integration, biopharmaceutical partnerships, regulatory experience, or specialized scientific infrastructure
• Demonstrates relevance in drug development, clinical trials, translational research, regulatory submissions, biomarker development, or therapeutic innovation
• Maintains systems for laboratory quality, chain of custody, regulatory compliance, data integrity, sample logistics, assay validation, and study-specific reporting

Routine-only patient testing laboratories, hospital laboratories without meaningful external research activity, software-only clinical trial vendors, and academic labs without scalable sponsor-facing laboratory services were generally excluded.

Methodology — Ranking Factors

Organizations included in the ranking were evaluated using a combination of qualitative and structural considerations rather than short-term financial performance alone. Key factors considered include:

• Scale and geographic reach of clinical trial laboratory operations
• Breadth of central lab, bioanalytical, biomarker, genomic, pathology, and preclinical testing services
• Ability to support global Phase I–IV clinical trials and complex study protocols
• Scientific expertise in assay development, validation, and translational research
• Data integration, sample tracking, biorepository, and logistics infrastructure
• Regulatory compliance, quality systems, GLP / GCP / GMP alignment, and audit readiness
• Relationships with pharmaceutical, biotechnology, medical device, academic, and CRO clients
• Institutional stability, scientific reputation, and long-term platform resilience

The objective of the ranking is to identify clinical trial and research laboratories whose platforms maintain sustained relevance within the global healthcare and life sciences ecosystem.

The Healthcare Ranking Top 20 Clinical Trial & Research Laboratories 2025 ranking evaluates organizations providing laboratory services for clinical trials, translational research, drug development, biomarker testing, bioanalysis, and regulated research programs.

The ranking universe consisted of approximately 120 clinical trial and research laboratory providers globally, from which 20 organizations were selected for inclusion.

Tier classifications reflect relative institutional positioning within the clinical trial and research laboratory segment and do not represent clinical outcome rankings, investment recommendations, or sponsor procurement advice.

---

Tier I — Leading Global Clinical Trial & Research Laboratories

Labcorp Central Laboratory Services

• Headquarters: Burlington, United States
• Founded: 1978
• Core focus: Central laboratory services, clinical trial testing, bioanalytical testing, precision medicine support

Labcorp Central Laboratory Services is one of the most important clinical trial laboratory platforms globally. The organization supports biopharmaceutical development through central laboratory testing, advanced diagnostics, bioanalytical services, precision medicine capabilities, and global laboratory data integration.

Labcorp’s strength lies in its combination of clinical laboratory scale and drug development infrastructure. Sponsors can access central laboratory testing, specialty diagnostics, biomarker capabilities, specimen logistics, and laboratory data management through a platform connected to one of the world’s largest diagnostic laboratory organizations.

The company is especially relevant in late-stage global trials, where protocol consistency, data reliability, sample logistics, turnaround time, and investigator-site support are critical. Labcorp’s central laboratory offering also supports precision medicine, reflecting the growing need to combine trial operations with molecular and biomarker testing.

As drug development becomes more complex and data-driven, Labcorp’s global reach, scientific breadth, laboratory infrastructure, and biopharmaceutical relationships support its position as a leading clinical trial and research laboratory provider.

IQVIA Laboratories / Q2 Solutions

• Headquarters: Durham, United States
• Founded: 2015
• Core focus: Central laboratories, specialty biomarker services, biospecimen management, clinical trial testing

IQVIA Laboratories, historically associated with Q2 Solutions, is one of the leading global clinical trial laboratory providers. The platform supports pharmaceutical and biotechnology sponsors through central laboratory services, specialty biomarker testing, biospecimen management, project management, data handling, and global trial support.

Its strength lies in the integration of laboratory science with IQVIA’s broader clinical research and data infrastructure. Clinical trial laboratories increasingly need to support not only sample analysis but also protocol design, biomarker strategy, patient stratification, data flow, and operational execution across global trial networks.

IQVIA describes its laboratories as providing drug discovery and development laboratory services with a global footprint, including central laboratory and specialty biomarker services. Q2 Solutions materials also describe central laboratories dedicated to clinical trial testing and associated services for trials worldwide.

The platform’s combination of central lab operations, specialty biomarker capability, sponsor relationships, clinical trial expertise, and data infrastructure supports its Tier I position.

ICON Central Laboratories

• Headquarters: Dublin, Ireland
• Founded: 1990
• Core focus: Global central laboratories, clinical trial testing, biomarker support, laboratory data

ICON Central Laboratories is a major global provider of central laboratory services for clinical trials. As part of ICON plc, the platform benefits from integration with a large contract research organization, allowing laboratory testing to be closely aligned with clinical trial operations, site management, data systems, and sponsor needs.

ICON’s central laboratory services are designed to provide harmonized laboratory data across global trials. This is particularly important for multinational studies where specimen collection, assay performance, reference ranges, logistics, and data transfer must remain consistent across regions.

The organization’s strength lies in its ability to connect scientific laboratory services with full-service clinical research execution. Sponsors can benefit from laboratory data management, protocol-specific workflows, logistics coordination, and trial operations expertise within a single broader research platform.

ICON’s global reach, CRO integration, laboratory data capabilities, and experience supporting drug development programs support its position among the leading clinical trial and research laboratory providers.

Thermo Fisher Scientific / PPD Laboratories

• Headquarters: Waltham, United States
• Founded: 1956
• Core focus: Clinical trial laboratories, bioanalytical testing, central labs, drug development services

Thermo Fisher Scientific, through PPD and related laboratory services, is one of the most important institutional platforms in clinical research laboratory services. Its offering spans bioanalytical laboratories, central laboratory support, vaccine sciences, biomarker testing, GMP laboratory services, and broader drug development infrastructure.

The platform’s strength lies in its breadth. Thermo Fisher combines laboratory services with clinical research, analytical technologies, manufacturing support, and life sciences tools. This gives it a distinctive position across the development continuum, from early research and preclinical testing to clinical trials and regulated product support.

In clinical trial laboratory services, PPD’s legacy capabilities provide sponsor-facing expertise in bioanalysis, pharmacokinetics, immunogenicity, vaccine testing, biomarker assays, and laboratory project management. These capabilities are especially relevant for biologics, vaccines, rare disease therapies, oncology, and advanced therapeutics.

Thermo Fisher’s scientific infrastructure, global operating scale, CRO integration, and technology depth support its position as a leading clinical trial and research laboratory provider.

Medpace Laboratories

• Headquarters: Cincinnati, United States
• Founded: 1992
• Core focus: Central laboratories, bioanalytical services, core labs, full-service clinical development support

Medpace Laboratories is a major clinical trial laboratory platform integrated within Medpace’s full-service clinical research organization. The company provides central laboratory services, bioanalytical testing, core laboratory services, imaging support, cardiac safety services, and specialty laboratory capabilities for pharmaceutical and biotechnology development.

Medpace’s strength lies in its integrated operating model. Sponsors, especially small and mid-sized biotechnology companies, often value laboratory services that are tightly connected to clinical operations, regulatory strategy, medical monitoring, and data management. Medpace’s laboratory platform supports this integrated trial model.

Medpace states that its central laboratories provide customized, high-quality laboratory services for pharma and biotech research and clinical development worldwide. Its broader core lab capabilities also include cardiac safety and imaging services, which are important for endpoint assessment in clinical trials.

Medpace’s laboratory breadth, CRO integration, scientific responsiveness, and relevance to biotech-sponsored trials support its inclusion among the leading providers in this category.

---

Tier II — Established Clinical Trial & Research Laboratories

(Alphabetical order)

ACM Global Laboratories

• Headquarters: Rochester, United States
• Founded: 1975
• Core focus: Central laboratory services, clinical trial testing, diagnostic laboratory support

ACM Global Laboratories is an established clinical trial laboratory provider offering central laboratory services, diagnostic testing, clinical trial testing, and laboratory project support for pharmaceutical, biotechnology, and research clients.

The organization’s strength lies in its experience supporting global and regional clinical trials with laboratory testing, specimen logistics, data reporting, and study-specific workflows. ACM is particularly relevant for sponsors seeking a central lab partner with clinical diagnostics roots and clinical research service capability.

Its platform supports routine safety testing, specialty assays, clinical trial sample management, and study coordination. ACM’s long-standing role in clinical trial laboratory services supports its inclusion among established providers.

Altasciences

• Headquarters: Laval, Canada
• Founded: 1992
• Core focus: Bioanalysis, early-phase clinical research, preclinical and clinical laboratory services

Altasciences is a research services provider with strong capabilities in bioanalysis, early-phase clinical trials, preclinical research, and laboratory services. Its platform is relevant for sponsors seeking integrated support from preclinical testing through first-in-human and early clinical development.

The company’s bioanalytical laboratories support pharmacokinetic, pharmacodynamic, and biomarker testing for small molecules, biologics, and other therapeutic modalities. These capabilities are especially important in early development, where sponsors need rapid, scientifically rigorous data to guide dosing, safety, and proof-of-mechanism decisions.

Altasciences’ strength lies in connecting laboratory science with early clinical execution. Its integrated model supports faster transitions between preclinical, bioanalytical, and clinical phases.

ARUP Laboratories

• Headquarters: Salt Lake City, United States
• Founded: 1984
• Core focus: Reference laboratory services, academic pathology, specialty research testing

ARUP Laboratories is a major nonprofit reference laboratory affiliated with the University of Utah. While best known for reference laboratory testing, ARUP also plays an important role in clinical research support, specialty diagnostics, assay development, and investigator-driven testing.

ARUP’s strength lies in its academic pathology and specialty testing depth. Clinical trials and research programs often require rare, complex, or specialized assays that are not available through routine central laboratories. ARUP’s reference laboratory model and expert interpretation make it relevant in these contexts.

Its academic affiliation supports scientific consultation, method development, pathology expertise, and diagnostic innovation. ARUP’s inclusion reflects the importance of academically linked laboratories in complex research and specialty clinical trial testing.

BioAgilytix

• Headquarters: Durham, United States
• Founded: 2008
• Core focus: Bioanalytical testing, immunogenicity, biomarkers, biologics and cell therapy support

BioAgilytix is a specialist bioanalytical laboratory provider focused on large molecule bioanalysis, immunogenicity testing, biomarker assays, cell-based assays, and laboratory support for biologics, biosimilars, vaccines, and cell and gene therapies.

The company’s relevance has increased as drug development has shifted toward biologically complex therapies. Monoclonal antibodies, fusion proteins, gene therapies, vaccines, and immune-modulating treatments require specialized assay design, validation, and regulated analysis.

BioAgilytix’s strength lies in scientific specialization rather than broad central laboratory scale. Its bioanalytical expertise supports pharmacokinetic, pharmacodynamic, and immunogenicity data that are essential to regulatory submissions and clinical decision-making in drug development.

Cerba Research

• Headquarters: Ghent / Paris, Belgium and France
• Founded: 1998
• Core focus: Clinical trial laboratories, specialty testing, biomarker services, central lab support

Cerba Research is a major clinical trial laboratory services provider connected to Cerba HealthCare’s broader diagnostics platform. The organization supports clinical development programs through central laboratory services, specialty testing, biomarker development, genomics, flow cytometry, pathology, and clinical trial sample management.

Cerba Research is especially relevant for complex and specialty clinical trials where sponsors require scientific consultation and assay flexibility. Its laboratory services support oncology, infectious disease, immunology, rare disease, and precision medicine studies.

The company’s strength lies in combining global clinical trial laboratory services with specialist scientific capabilities. Its connection to a broader healthcare diagnostics organization also supports access to pathology expertise, clinical laboratory infrastructure, and international laboratory operations.

Charles River Laboratories

• Headquarters: Wilmington, United States
• Founded: 1947
• Core focus: Preclinical research, safety assessment, biologics testing, laboratory animal science

Charles River Laboratories is one of the most important research laboratory providers in preclinical drug development. The company supports pharmaceutical, biotechnology, academic, and government clients through discovery services, safety assessment, toxicology, research models, biologics testing, and laboratory services.

Charles River’s relevance lies in the preclinical and translational stages of drug development. Before therapies enter human trials, sponsors require evidence on safety, pharmacology, toxicology, biological activity, and product quality. Charles River’s laboratory infrastructure supports these requirements across multiple therapeutic modalities.

Its strength is its scientific breadth and established position in regulated preclinical testing. As drug development expands into biologics, cell therapies, gene therapies, and complex modalities, preclinical research laboratories remain foundational to translational progress.

Eurofins BioPharma Services

• Headquarters: Luxembourg
• Founded: 1987
• Core focus: BioPharma product testing, central laboratory services, analytical testing, clinical research support

Eurofins BioPharma Services is one of the most important laboratory services platforms for pharmaceutical, biopharmaceutical, and medical device development. The organization provides analytical testing, GMP testing, biologics testing, product characterization, clinical trial laboratory services, central lab support, and specialty testing.

Eurofins’ strength lies in its broad scientific laboratory infrastructure. The group operates across many analytical domains, allowing it to support drug development, manufacturing quality, product release, stability testing, method development, and clinical research needs.

The company’s biopharma product testing network is especially important for regulated development and manufacturing support. Clinical trial and research laboratories are increasingly tied to product quality, companion testing, and biologic characterization, making Eurofins a major participant in the broader research laboratory sector.

Frontage Laboratories

• Headquarters: Exton, United States
• Founded: 2001
• Core focus: Bioanalytical services, drug metabolism, pharmacokinetics, clinical research laboratories

Frontage Laboratories provides laboratory and clinical research services supporting drug discovery and development. Its capabilities include bioanalytical testing, drug metabolism and pharmacokinetics, analytical services, clinical trial support, and laboratory testing for pharmaceutical and biotechnology clients.

The company’s relevance lies in its integrated drug development laboratory model. Sponsors require bioanalytical data to understand exposure, metabolism, safety, and biological effect. Frontage supports these needs across small molecules, biologics, and specialty development programs.

Its combination of laboratory science, clinical research support, and sponsor-facing development services places it among established clinical trial and research laboratory providers.

KCAS Bioanalytical and Biomarker Services

• Headquarters: Olathe, United States
• Founded: 1979
• Core focus: Bioanalysis, biomarkers, immunogenicity, mass spectrometry, flow cytometry

KCAS Bioanalytical and Biomarker Services is a specialist research laboratory provider focused on bioanalysis, biomarker testing, immunogenicity, mass spectrometry, flow cytometry, and regulated laboratory support for drug development.

The company’s strength lies in its scientific focus. Bioanalytical and biomarker laboratories are essential for measuring drug exposure, immune response, target engagement, and biological activity in clinical and preclinical studies.

KCAS is especially relevant for sponsors developing biologics, cell and gene therapies, small molecules, immunotherapies, and complex therapeutic programs where specialized assays are required. Its technical depth supports its position among established research laboratory providers.

MLM Medical Labs

• Headquarters: Mönchengladbach, Germany
• Founded: 1993
• Core focus: Central laboratory services, clinical trial testing, biomarker laboratories

MLM Medical Labs is a European clinical trial laboratory provider offering central laboratory services, biomarker testing, logistics, kit management, and specialty laboratory support for clinical research programs.

The organization is relevant for sponsors seeking flexible, science-oriented laboratory support in Europe and global clinical development. Its capabilities include routine safety testing, specialty assays, sample management, and study-specific laboratory workflows.

MLM’s strength lies in its clinical trial laboratory focus and European positioning. As sponsors increasingly run complex multinational studies, specialized central labs with strong operational execution and scientific flexibility remain valuable.

---

Tier III — Specialist Clinical Trial & Research Laboratories

(Alphabetical order)

• Celerion
• LabConnect
• Mayo Clinic Laboratories
• Precision for Medicine Biomarker Labs
• WuXi AppTec Laboratory Testing Division

---

Remarks

Clinical trial and research laboratories continue to serve as essential infrastructure for pharmaceutical, biotechnology, medical device, and academic research. Their role extends beyond sample testing into protocol execution, biomarker strategy, assay validation, data integrity, regulatory readiness, biospecimen logistics, and translational science.

The organizations recognized in this ranking represent providers whose laboratory platforms maintain sustained relevance across central laboratories, bioanalysis, biomarker testing, preclinical research, specialty diagnostics, sample management, and clinical trial data generation. Tier classification reflects relative institutional positioning within the clinical trial and research laboratory sector rather than direct sponsor preference, investment recommendation, or regulatory endorsement.

Tier classification reflects relative laboratory scale, scientific depth, regulatory capability, global reach, assay complexity, data infrastructure, sponsor relationships, and long-term platform resilience. The ranking does not constitute a procurement recommendation, investment recommendation, clinical endorsement, or evaluation of individual scientists, laboratory directors, or investigators.

---

Recognition

Organizations included in the Top 20 Clinical Trial & Research Laboratories 2025 ranking may request information regarding authorized use of the Ranking News designation for marketing and communications purposes.

Recognized institutions may reference the designation in:

• corporate websites
• investor communications
• marketing materials
• institutional presentations
• academic and recruitment materials

Licensing inquiries:
[email protected]